CG Oncology Inc. (CGON) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for CG Oncology Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Valuation | |||||
| P/E Ratio | -19.94x | -20.36x | -50.96x | -69.88x | -192.92x |
| P/B Ratio | 4.26x | 2.44x | 13.40x | 19.79x | 61.53x |
| P/S Ratio | 794.47x | 1573.67x | 12141.52x | 12967.90x | 239.13x |
| Profitability | |||||
| Gross Margin | -15.0% | 100.0% | 100.0% | 92.1% | 99.9% |
| Operating Margin | -4722.1% | -10067.3% | -27180.9% | -18453.4% | -121.7% |
| Net Margin | -3985.0% | -7729.5% | -23827.0% | -18556.5% | -124.0% |
| EBITDA Margin | -3949.3% | -10064.4% | -27172.5% | -18445.5% | -119.5% |
| Liquidity | |||||
| Current Ratio | 24.63x | 35.30x | 13.62x | 9.54x | 9.78x |
| Quick Ratio | 24.58x | 35.30x | 13.62x | 9.54x | 9.78x |
| Leverage | |||||
| Debt/Equity | 0.01x | 0.00x | 0.01x | 0.13x | 0.38x |
YoY = year-over-year change. Source: FMP..